These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 573978)

  • 1. Pyrazidol, a new drug with antidepressant properties.
    Mashkovsky MD; Andreyeva NI
    Ann Ist Super Sanita; 1978; 14(1):43-8. PubMed ID: 573978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study of the mechanism of action of the new antidepressant pyrazidol].
    Mashkovskiĭ MD; Gorkin VZ; Andreeva NI; Verevkina IV; Siniukhin VN
    Farmakol Toksikol; 1975; 38(5):531-6. PubMed ID: 1183581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Selective inhibition of type A monoamine oxidase by pyrazidol].
    Mashkovskiĭ MD; Gorkin VZ; Verevkina IV; Asnina VV; Tupikina SM
    Biull Eksp Biol Med; 1981 Feb; 91(2):169-71. PubMed ID: 7225552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Selective inhibition by pyrazidol of monoamine oxidase type A in different human and animal tissues].
    Verevkina IV; Asnina VV; Gorkin VZ; Mashkovskiĭ MD
    Vopr Med Khim; 1983; 29(5):118-23. PubMed ID: 6649522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhibition of brain monoamine oxidase in the rat by multiple pyrazidol administration].
    Verevkina IV; Asnina VV; Gorkin VZ; Mashkovskiĭ MD
    Biull Eksp Biol Med; 1985 May; 99(5):583-4. PubMed ID: 4005414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of various antidepressive agents on brain monoamine oxidase activity].
    Gankina EM; Moskvitina TA; Gorkin VZ; Val'dman AV
    Biull Eksp Biol Med; 1982 Nov; 94(11):29-31. PubMed ID: 7150732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of pyrazidole and deprenyl on monoamine oxidase in the rat intestine].
    Mashkovskiĭ MD; Gorkin VZ; Asnina VV; Verevkina IV
    Biull Eksp Biol Med; 1981 Mar; 91(3):309-11. PubMed ID: 6788108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurophysiological and biochemical aspects in the action of antidepressant drugs.
    Benesová O
    Act Nerv Super (Praha); 1970; 12(3):226-34. PubMed ID: 4917579
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation.
    Youdim MB; Weinstock M
    Neurotoxicology; 2004 Jan; 25(1-2):243-50. PubMed ID: 14697899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mechanism of the pyrazidol potentiation of the hyperglycemic effect of adrenaline].
    Egorova EF; Liberman SS
    Farmakol Toksikol; 1978; 41(1):36-40. PubMed ID: 624387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New studies on the use of antidepressants].
    Deniker P; Loo H; Zarifian E
    Ann Med Psychol (Paris); 1980 Jan; 138(1):103-13. PubMed ID: 6104461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The comparative influence of pyrazidol, inkazan and other antidepressant monoamine oxidase inhibitors on the pressor effect of tyramine].
    Andreeva NI; Golovina SM; Faermark MF; Shvarts GIa; Mashkovskiĭ MD
    Farmakol Toksikol; 1991; 54(2):38-40. PubMed ID: 1884793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel strategies for pharmacotherapy of depression.
    Maubach KA; Rupniak NM; Kramer MS; Hill RG
    Curr Opin Chem Biol; 1999 Aug; 3(4):481-8. PubMed ID: 10419849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanism of the qualitative modification of mitochondrial monoamine oxidase activity by pyrazidol].
    Baumanis EA; Birska IA; Reĭkman GO; Kirule IE; Shvedov VI
    Vopr Med Khim; 1987; 33(6):90-6. PubMed ID: 3445553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of psychotropic substances on the deamination of monoamines in the rat brain].
    Gol'dina OA; Gankina EM
    Farmakol Toksikol; 1988; 51(4):22-5. PubMed ID: 3191966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of TV3326, a novel monoamine-oxidase cholinesterase inhibitor, in rat models of anxiety and depression.
    Weinstock M; Poltyrev T; Bejar C; Youdim MB
    Psychopharmacology (Berl); 2002 Mar; 160(3):318-24. PubMed ID: 11889501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Some biochemical properties of the new potential antidepressant agent N-methyl-N-propargyl-2-(1-methyl-5-methoxyindolyl)methylamine.
    Carranza Gómez-Carpintero M; Ochoa Estomba MC
    Arzneimittelforschung; 1993 Sep; 43(9):937-41. PubMed ID: 8240453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Newer formazans and tetrazolium indoles as potential CNS-active agents.
    Sathi G; Gujrati VR; Nath C; Agarwal JC; Bhargava KP; Shanker K
    Arzneimittelforschung; 1983; 33(9):1218-21. PubMed ID: 6685502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Properties of intestinal monoamine oxidase in the rat].
    Verevkina IV; Asnina VV; Gorkin VZ
    Vopr Med Khim; 1982; 28(2):88-93. PubMed ID: 7080482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversible monoamine oxidase-A inhibitors in resistant major depression.
    Nolen WA; Hoencamp E; Bouvy PF; Haffmans PM
    Clin Neuropharmacol; 1993; 16 Suppl 2():S69-76. PubMed ID: 8313400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.